Repligen (RGEN) Gross Margin Growth (3y) (2013 - 2026)
Analysis
Repligen (RGEN) Gross Margin Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 24.00 |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | 151.00 |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 1,613.00 |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | 419.00 |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | 39.00 |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | -212.00 |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | -10.00 |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | 373.00 |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | 664.00 |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | -32.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 373.00 |
| Mar 31, 2026 | 523.00 |
| Dec 31, 2025 | 103.00 |
| Sep 30, 2025 | -367.00 |
| Jun 30, 2025 | -746.00 |
| Mar 31, 2025 | -609.00 |
| Dec 31, 2024 | -3,283.00 |
| Sep 30, 2024 | -760.00 |
| Jun 30, 2024 | -1,063.00 |
| Mar 31, 2024 | -804.00 |
| Dec 31, 2023 | -857.00 |
| Sep 30, 2023 | -3,198.00 |
| Jun 30, 2023 | -768.00 |
| Mar 31, 2023 | -746.00 |
| Dec 31, 2022 | -521.00 |
| Sep 30, 2022 | 215.00 |
| Jun 30, 2022 | 189.00 |
| Mar 31, 2022 | 437.00 |
| Dec 31, 2021 | 143.00 |
| Sep 30, 2021 | 243.00 |